Search

everythinglearnresearchcommunity

for

Search:↓

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

New methods are being developed to improve drug delivery to the brain.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Neurosteroids may help metyrapone reduce cocaine addiction.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

The man's symptoms improved and the tumor shrank after treatment with cabergoline.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Certain drugs can change hair color, either lightening or darkening it.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Certain substances can decrease or increase exploratory behavior in rodents.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.